-
04.23 2021
Dentsu Ventures Invests in Overtime, a U.S.-Based Company which Runs a Sports Platform and Community for Young Fans
-
04.02 2020
Cue Health Awarded $13 Million for Rapid, Portable, Point-of-Care COVID-19 Test by U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority ("BARDA")
-
11.07 2018
Dentsu Ventures Invests in Clear Labs, Provider of a Cutting-edge Genetic Analysis Platform for Food in the United States
-
10.11 2018
Dentsu Ventures Invests in Pixel Labs, a Company Developing and Providing a Platform that Automatically Generates Hyper-Local News Content in the United States
-
4.3 2018
Dentsu Ventures Investment in Arraiy, a Developer of Computer Vision and Machine Learning Platforms for Video Creators
-
3.27 2018
Dentsu Ventures Investment in Cheddar Inc., which Produces and Distributes News Videos that Meet the Needs of Modern Viewers in the United States
-
11.15 2017
Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the United States
-
6.13 2017
Dentsu Ventures Investment in Grail, a Developer of Blood Testing Techniques for the Early Detection of Cancer in the United States
Portfolio
Funds Under Management

Dentsu Ventures Global Fund I
- Partners:
- Prime Partners, Inc. and Dentsu Inc.
- Total fund capital:
- 10 billion yen
Dentsu Ventures Fund Ⅱ
- Partners:
- Prime Partners, Inc., Dentsu Group Inc. and Dentsu Innovation Partners ,Inc.
- Total fund capital:
- 10 billion yen


BRICKS FUND TOKYO I Investment Limited Partnership
- Partners:
- Prime Partners, Inc. and Mitsubishi Estate Co., Ltd.
- Total fund capital:
- 10 billion yen